The role of the active site Zn in the catalytic mechanism of the GH38 Golgi α-mannosidase II: Implications from noeuromycin inhibition

References

• Brunger AT, Adams PD, Clore GM, DeLano WL, Gros P, Grosse-Kunstleve RW, Jiang JS, Kuszewski J, Nilges M, Pannu NS, et al. Crystallography & NMR system: A new software suite for macromolecular structure determination. Acta Crystallogr D Biol Crystallogr 1998; 54(Pt 5)905–21
   PubMedGoogle Scholar
• Davies GJ, Mackenzie L, Varrot A, Dauter M, Brzozowski AM, Schulein M, Withers SG. Snapshots along an enzymatic reaction coordinate: Analysis of a retaining beta-glycoside hydrolase. Biochemistry 1998; 37(34)11707–11713
   PubMed Web of Science ®Google Scholar
• Dowd MK, French AD, Reilly PJ. Modeling of Aldopyranosyl Ring Puckering with Mm3(92). Carbohydr Res 1994; 264(1)1–19
   Google Scholar
• Gloster TM, Roberts S, Ducros VMA, Perugino G, Rossi M, Hoos R, Moracci M, Vasella A, Davies GJ. Structural studies of the beta-glycosidase from Sulfolobus solfataricus in complex with covalently and noncovalently bound inhibitors. Biochemistry 2004; 43(20)6101–6109
   PubMedGoogle Scholar
• Goss PE, Baker MA, Carver JP, Dennis JW. Inhibitors of carbohydrate processing: A new class of anticancer agents. Clin Cancer Res 1995; 1(9)935–44
   PubMed Web of Science ®Google Scholar
• Goss PE, Baptiste J, Fernandes B, Baker M, Dennis JW. A phase I study of swainsonine in patients with advanced malignancies. Cancer Res 1994; 54(6)1450–7
   PubMed Web of Science ®Google Scholar
• Goss PE, Reid CL, Bailey D, Dennis JW. Phase IB clinical trial of the oligosaccharide processing inhibitor swainsonine in patients with advanced malignancies. Clin Cancer Res 1997; 3(7)1077–86
   PubMed Web of Science ®Google Scholar
• Harding MM. Geometry of metal-ligand interactions in proteins. Acta Crystallogr D Biol Crystallogr 2001; 57(Pt 3)401–11
   PubMedGoogle Scholar
• Harding MM. The architecture of metal coordination groups in proteins. Acta Crystallogr D Biol Crystallogr 2004; 60(Pt 5)849–59
   PubMedGoogle Scholar
• Jensen MH, Mirza O, Albenne C, Remaud-Simeon M, Monsan P, Gajhede M, Skov LK. Crystal structure of the covalent intermediate of amylosucrase from Neisseria polysaccharea. Biochemistry 2004; 43(11)3104–3110
   PubMedGoogle Scholar
• Jones, TA, Zou, JY, Cowan, SW, Kjeldgaard. 1991. Improved methods for building protein models in electron density maps and the location of errors in these models. Acta Crystallogr, A 47 ( Pt 2):110–9.
   Google Scholar
• Kavlekar LM, Kuntz DA, Wen X, Johnston BD, Svensson B, Rose DR, Pinto BM. 5-Thio-D-glycopyranosylamines and their amidinium salts as potential transition-state mimics of glycosyl hydrolases: synthesis, enzyme inhibitory activities, X-ray crystallography, and molecular modeling. Tetrahedron-Asymmetry 2005; 16(5)1035–1046
   Google Scholar
• Kuntz DA, Ghavami A, Johnston BD, Pinto BM, Rose DR. Crystallographic analysis of the interactions of Drosophila melanogaster Golgi alpha-mannosidase II with the naturally occurring glycomimetic salacinol and its analogues. Tetrahedron-Asymmetry 2005; 16(1)25–32
   Google Scholar
• Liu H, Liang X, Sohoel H, Bulow A, Bols M. Noeuromycin, a glycosyl cation mimic that strongly inhibits glycosidases. J Am Chem Soc 2001; 123(21)5116–7
   PubMedGoogle Scholar
• MacKenzie LF, Sulzenbacher G, Divne C, Jones TA, Woldike HF, Schulein M, Withers SG, Davies GJ. Crystal structure of the family 7 endoglucanase I (Cel7B) from Humicola insolens at 2.2 A resolution and identification of the catalytic nucleophile by trapping of the covalent glycosyl-enzyme intermediate. Biochem J 1998; 335(Pt 2)409–16
   PubMedGoogle Scholar
• Mulakala C, Reilly PJ. Understanding protein structure-function relationships in family 47 alpha-1,2-mannosidases through computational docking of ligands. Proteins-Structure Funct Genet 2002; 49(1)125–134
   PubMedGoogle Scholar
• Notenboom V, Birsan C, Nitz M, Rose DR, Warren RA, Withers SG. Insights into transition state stabilization of the beta-1,4- glycosidase Cex by covalent intermediate accumulation in active site mutants. Nat Struct Biol 1998; 5(9)812–8
   PubMedGoogle Scholar
• Numao S, Kuntz DA, Withers SG, Rose DR. Insights into the mechanism of Drosophila melanogaster Golgi alpha-mannosidase II through the structural analysis of covalent reaction intermediates. J Biol Chem 2003; 278(48)48074–83
   PubMedGoogle Scholar
• Otwinowski Z, Minor W. Processing of X-ray Diffraction Data Collected in Oscillation Mode. Meth Enzymol 1997; 276: 307–26
   PubMed Web of Science ®Google Scholar
• Rabouille C, Kuntz DA, Lockyer A, Watson R, Signorelli T, Rose DR, van den Heuvel M, Roberts DB. The Drosophila GMII gene encodes a Golgi alpha-mannosidase II. J Cell Sci 1999; 112(Pt 19)3319–30
   PubMedGoogle Scholar
• Sabini E, Wilson KS, Danielsen S, Schulein M, Davies GJ. Oligosaccharide binding to family 11 xylanases: both covalent intermediate and mutant product complexes display (2,5)B conformations at the active centre. Acta Crystallogr D Biol Crystallogr 2001; 57(Pt 9)1344–7
   PubMedGoogle Scholar
• Shah N, Kuntz DA, Rose DR. Comparison of kifunensine and 1-deoxymannojirimycin binding to class I and II alpha-mannosidases demonstrates different saccharide distortions in inverting and retaining catalytic mechanisms. Biochemistry 2003; 42(47)13812–6
   PubMedGoogle Scholar
• Stoddart, JF. 1971. Stereochemistry of carbohydrates. New York: Wiley-Interscience.
   Google Scholar
• Sulzenbacher G, Bignon C, Nishimura T, Tarling CA, Withers SG, Henrissat B, Bourne Y. Crystal structure of Thermotoga maritima alpha-L-fucosidase-Insights into the catalytic mechanism and the molecular basis for fucosidosis. J Biol Chem 2004; 279(13)13119–13128
   PubMedGoogle Scholar
• van den Elsen JM, Kuntz DA, Rose DR. Structure of Golgi alpha-mannosidase II: a target for inhibition of growth and metastasis of cancer cells. Embo J 2001; 20(12)3008–17
   PubMedGoogle Scholar
• Varrot A, Yip VLY, Li YS, Rajan SS, Yang XJ, Anderson WF, Thompson J, Withers SG, Davies GJ. NAD(+) and metal-ion dependent hydrolysis by family 4 glycosidases: Structural insight into specificity for phospho-beta-D-glucosides. J Molec Biol 2005; 346(2)423–435
   PubMedGoogle Scholar
• Vincent F, Gloster TM, Macdonald J, Morland C, Stick RV, Dias FMV, Prates JAM, Fontes CMGA, Gilbert HJ, Davies GJ. Common inhibition of both beta-glucosidases and beta-mannosidases by isofagomine lactam reflects different conformational itineraries for pyranoside hydrolysis. Chembiochem 2004; 5(11)1596–1599
   PubMedGoogle Scholar
• White A, Tull D, Johns K, Withers SG, Rose DR. Crystallographic observation of a covalent catalytic intermediate in a beta-glycosidase. Nat Struct Biol 1996; 3(2)149–54
   PubMedGoogle Scholar